IL17A and autoimmune disease: Recently, IL-2 has been increasingly used in treating autoimmune diseases, which may involve the following mechanisms: (i) Selective activation and expansion of Treg cells (15–20); (ii) inhibition of the differentiation of follicular helper T and helper T (Th17) cells that produce IL-17 (15, 20–22).